Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002
Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002
Cell Transplantation For Stroke
Ann Neurol 52:266-275, Savitz,S.I.,et al, 2002
Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002
Acute Confusional State Following Liver Transplantation for Alcoholic Liver Disease
Neurol 59:601-605, Buis,C.I.,et al, 2002
Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002
Is a "Vanishing Tumor" Always a Lymphoma?
Neurol 59:762-764, Bromberg,J.E.C.,et al, 2002
Assessment of Normal-Appearing White and Gray Matter in Patients with Primary Progressive Multiple Sclerosis
Arch Neurol 59:1406-1412, Rovaris,M.,et al, 2002
Proton MR Spectroscopy of Tumefactive Demyelinating Lesions
AJNR 23:1378-1386, Saindane,A.M.,et al, 2002
Acute Disseminated Encephalomyelitis
Neurol 59:1224-1231, Tenembaum,S.,et al, 2002
Poliomyelitis Due to West Nile Virus
NEJM 347:1280-1281, Glass,J.D.,et al, 2002
West Nile Virus Encephalitis
NEJM 347:1225-1226, Peterson,L.R.,et al, 2002
Brain Calcifications in Systemic Sclerosis
Arch Neurol 59:1642-1643, Gusbi,O. &Bernardini,G.L., 2002
Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002
MRI Predictors of Early Conversion to Clinically Definite MS in the CHAMPS Placebo Group
Neurol 59:998-1005, CHAMPS Study Group, 2002
Therapy-Related Acute Myeloblastic Leukemia After Mitoxantrone Treatment in a Patient with MS
Neurol 59:954-955, Brassat,D.,et al, 2002
Cardiac Adverse Effects Associated with Mitoxantrone (Novantrone) Therapy in Patients with MS
Neurol 59:909-913, Ghalie,R.G.,et al, 2002
Prognosis for Gross Motor Function in Cerebral Palsy
JAMA 288:1357-1363,1399, Rosenbaum,P.L., et al, 2002
A Blinding Combination
Lancet 360:1220, Matthews,B.N.,et al, 2002
A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002
Cause and Prognosis of Nontraumatic Sixth Nerve Palsies in Young Adults
Ophthalmology 109:1925-1928, Peters III,G.B.,et al, 2002
Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002
Severe Neurologic Complications After Hematopoietic Stem Cell Transplantation in Children
Neurol 59:1895-1904,E13, Farci,M.,et al, 2002
An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002
Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002
A Longitudinal Study of Abnormalities on MRI and Disability From Multiple Sclerosis
NEJM 346:158-164,199, Brex,P.A.,et al, 2002
Plasma Exchange for Severe Attacks of CNS: Demyelination: Predictors of Response
Neurol 58:143-146, Keegan,M.,et al, 2002
Predictors of Functional Disability and Mortality After Status Epilepticus
Neurol 58:139-142, Claassen,J.,et al, 2002
Serial MRI Findings in a Case of Primary Lateral Sclerosis
Neurol 58:647-649, Smith,C.D., 2002
Clinicopath Conf, Hyperviscosity Syndrome Due to IgG Multiple Myeloma
NEJM 346:603-610, Case 6-2002, 2002
Familial Amyotrophic Lateral Sclerosis
Muscle Nerve 25:135-159, Hand,C.K. &Rouleau,G.A., 2002
Fractures After Stroke
Stroke 33:728-734, Dennis,M.S.,et al, 2002
Falls, Fractures, and Osteoporosis After Stroke
Stroke 33:1432-1436, Poole,K.E.S.,et al, 2002
Euthanasia and Physician-Assisted Suicide Among Patients with Amyotrophic Lateral Sclerosis in the Netherlands
NEJM 346:1638-1644, Veldink,J.H.,et al, 2002
Hyperammonemic Encephalopathy in Multiple Myeloma
NEJM 346:1674-1675, Kwan,L.,et al, 2002
Treatment of Spinal Epidural Metastasis Improves Patient Survival and Functional State
Neurol 58:1360-1366, Zaidat,O.O &Ruff,R.L., 2002
Antiepileptic Drug-Induced Bone Loss in Young Male Patients Who Have Seizures
Arch Neurol 59:781-786, Andress,D.L.,et al, 2002
Effect of Antiepileptic Drugs on Bone Density in Ambulatory Patients
Neurol 58:1348-1353, Farhat,G.,et al, 2002
Multiple Sclerosis
Lancet 359:1221-1231, Compston,A. &Coles,A., 2002
Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS
Neurol 58:1404-1407,1323, Killestein,J.,et al, 2002
Patients with Multiple Sclerosis and Risk of Type 1 Diabetes Mellitus in Sardinia,Italy: A Cohort Study
Lancet 359:1461-1465,1450, Marrosu,M.G.,et al, 2002
Abnormal Diffusion-Weighted Magnetic Resonance Imaging in Creutzfeldt-Jakob Disease Following Corneal Transplantations
Arch Neurol 59:637-639, Rabinstein,A.A.,et al, 2002
Results of Radiotherapy for Drooling in Amyotrophic Lateral Sclerosis
Neurol 58:1308, Stalpers,L.J.A. &Moser,E.C., 2002
Efficacy and Safety of Modafinil (Provigil) for the Treatment of Fatigue in Multiple Sclerosis: A Two Centre Phase 2 Study
JNNP 72:179-183,150, Rammohan,K.W.,et al, 2002
Incidence of Acute Femoral Neuropathy Following Renal Transplantation
Arch Neurol 59:541-545, Sharma,K.R.,et al, 2002
Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging
Radiology 223:46-56, Bot,J.C.J.,et al, 2002
Sandlike Appearance of Virchow-Robin Spaces in Early Multiple Sclerosis:A Novel Neuroradiologic Marker
AJNR 23:376-380, Achiron,A.&Faibel,M., 2002
Recent Developments in Neurology
BMJ 324:656-660, Wiebe,S.,&Nicolle,M.W., 2002
Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002
Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002